Department of Medical Oncology, Cancer Center, West China Hospital, 34753Sichuan University, Chengdu, People's Republic of China.
Cancer Control. 2022 Jan-Dec;29:10732748221112664. doi: 10.1177/10732748221112664.
Psychotherapy is considered part of the standard treatment of cancer in Western countries. However, there is no literature on the attitudes of Chinese cancer patients toward psychotherapy.
In a multicenter, cross-sectional study in China, a homemade questionnaire was delivered to cancer patients. The targeted population was Chinese hospitalized cancer patients who were informed of their state of illness.
Five hundred and fifty cancer patients received our questionnaire, and 83.3% completed the questionnaire. Among the 458 patients, 43.2% indicated that they had never heard of psychotherapy before the survey. However, after a brief introduction of psychotherapy, most (92.1%) cancer patients indicated that psychotherapy is essential for cancer patients, and over half of patients (57.4%) were willing to take psychotherapy on the advice of the oncologist in charge. Participants aged 45 years or younger, had a family income > 10000 yuan per month, and had an ECOG PS (Eastern Cooperative Oncology Group Performance Status) of 2-4 were more willing to receive psychotherapy. Of all patients, 59.2% and 57.6% were willing to participate in individual and group psychotherapy clinical trials, respectively. Participants who had a bachelor's degree or higher (odds ratio, OR = 2.09) and were aged 45 years or younger (OR = 1.67) were more willing to participate in individual and group psychotherapy clinical trials, respectively.
The unmet psychological needs of cancer patients in China remain high, and doctors' advice is likely to positively impact the patients' acceptance of psychotherapy. Psychological education for Chinese cancer patients should be strengthened. More high-quality clinical trials of psychotherapy should be conducted in China to achieve greater benefits for cancer patients and their families.
在西方国家，心理治疗被认为是癌症标准治疗的一部分。然而，目前尚缺乏关于中国癌症患者对心理治疗态度的相关文献。
本研究采用多中心、横断面调查方法，在中国开展此项研究，向癌症患者发放自制问卷。目标人群为已获知自身疾病状况的住院癌症患者。
共 550 例癌症患者收到我们的问卷，其中 83.3%完成了问卷。在 458 例患者中，43.2%表示在调查前从未听说过心理治疗。然而，在简要介绍心理治疗后，大多数（92.1%）癌症患者表示心理治疗对癌症患者很重要，超过一半的患者（57.4%）愿意根据主管肿瘤医生的建议接受心理治疗。年龄在 45 岁及以下、家庭月收入>10000 元、ECOG PS（东部肿瘤协作组体力状况评分）为 2-4 的患者更愿意接受心理治疗。所有患者中，分别有 59.2%和 57.6%愿意参加个体和团体心理治疗临床试验。本科及以上学历者（比值比，OR=2.09）和年龄在 45 岁及以下者（OR=1.67）更愿意参加个体和团体心理治疗临床试验。
中国癌症患者的心理需求仍未得到满足，医生的建议可能会对患者接受心理治疗产生积极影响。应加强对中国癌症患者的心理教育。应在中国开展更多高质量的心理治疗临床试验，为癌症患者及其家属带来更大的获益。
